As expected, the study utilised network pharmacology predictions to determine that the AMPK signalling pathway is significantly involved in the therapeutic effects of rhubarb for NAFLD, as indicated by the KEGG enrichment results. This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.